Hi jj, that's definitely a nice read. They stated as much in the...

Hi jj, that's definitely a nice read. They stated as much in the preso late last year but the words here refresh and reinforce that so I would hope that genuine dialogues are underway. The following statement clarifies that P1 is estimated (based on these conversations) to be sufficient to move to license arrangements (ie P2 is not required if safety and efficacy hold up).

Also love to see new patents being approved globally. The Sep Qtr updated on filings this quarter a nice set of approvals.

Would have liked an update on Accugen also. Feel it's hidden away at the moment.
I